Washington Trust Bank Lowers Stake in Vertex Pharmaceuticals

Washington Trust Bank cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the period. Vertex Pharmaceuticals comprises approximately 1.3% of Washington Trust […]

Related Keywords

Washington , United States , Ourania Tatsis , Brucei Sachs , Ethic Inc , Vertex Pharmaceuticals Stock Performance , Vertex Pharmaceuticals Incorporated , Cantor Fitzgerald , News Ratings For Vertex Pharmaceuticals Daily , Vertex Pharmaceuticals , Washington Trust Bank , Caxton Associates , Quarter For Vertex Pharmaceuticals , Wolfe Research , Regal Investment Advisors , Icon Wealth Advisors , Nasdaq , Free Report , Trust Bank , Wealth Advisors , Investment Advisors , Director Bruce , Pharmaceuticals Incorporated , Get Free Report , Visit Holdingschannel , Vertex Pharmaceuticals Daily ,